Barbara Mikulski actually said...

This is a local, State and national problem that, unfortunately, affects all of us.

The FDA lacks authority to require notification from manufacturers when a plant shuts down, which could lead to a drug shortage.

There is such compelling interest in this issue in Maryland from iconic institutions like Hopkins and the University of Maryland.

I have heard from Maryland hospitals, doctors, nurses and patients that drug shortages are a serious problem with serious consequences.